Stay updated on Nusinersen Safety in SMA Clinical Trial
Sign up to get notified when there's something new on the Nusinersen Safety in SMA Clinical Trial page.

Latest updates to the Nusinersen Safety in SMA Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the Nusinersen study is displayed with its study details, eligibility criteria, outcome measures, results links, and record history.SummaryDifference61%

- Check11 days agoChange DetectedThe page remains a 403 Forbidden error; the footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoChange DetectedA banner announces an NIH-wide transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer’s revision indicator changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the EMBRACE study details and related links; this indicates the study record is currently inaccessible due to a permissions issue.SummaryDifference20%

Stay in the know with updates to Nusinersen Safety in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nusinersen Safety in SMA Clinical Trial page.